Log in
Enquire now
‌

US Patent 11371030 Modified Cas9 protein and use thereof

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
The University of Tokyo Edge Capital
The University of Tokyo Edge Capital
Date Filed
May 31, 2018
Date of Patent
June 28, 2022
Patent Applicant
The University of Tokyo Edge Capital
The University of Tokyo Edge Capital
Patent Application Number
16617498
Patent Citations
‌
US Patent 10202589 Engineered CRISPR-Cas9 nucleases with altered PAM specificity
‌
US Patent 10479982 Engineered CRISPR-Cas9 nucleases with altered PAM specificity
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11371030
Patent Primary Examiner
‌
Delia M. Ramirez
CPC Code
‌
C12N 15/09
‌
C12N 9/22
‌
C07K 2319/50
‌
C07K 2319/21
‌
C12N 15/113

Find more entities like US Patent 11371030 Modified Cas9 protein and use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.